{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:54Z","timestamp":1787027034925,"version":"build-2736575974"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Duchenne muscular dystrophy (DMD) is a striated muscle degenerative disease due to loss of functional dystrophin protein. Loss of dystrophin results in susceptibility of muscle membranes to damage, leading to muscle degeneration and continuous inflammation and fibrosis that further exacerbate pathology. Long-term glucocorticoid receptor (GR) agonist treatment, the current standard-of-care for DMD, modestly improves prognosis but has serious side effects. The mineralocorticoid receptor (MR), a ligand-activated transcription factor present in many cell types, has been implicated as a therapeutic target for DMD. MR antagonists (MRAs) have fewer side effects than GR agonists and are used clinically for heart failure. MRA efficacy has recently been demonstrated for DMD cardiomyopathy and in preclinical studies, MRAs also alleviate dystrophic skeletal muscle pathology. MRAs lead to improvements in muscle force and membrane stability and reductions in degeneration, inflammation, and fibrosis in dystrophic muscles. Myofiber-specific MR knockout leads to most of these improvements, supporting an MR-dependent mechanism of action, but MRAs additionally stabilize myofiber membranes in an MR-independent manner. Immune cell MR signaling in dystrophic and acutely injured normal muscle contributes to wound healing, and myeloid-specific MR knockout is detrimental. More research is needed to fully elucidate MR signaling in striated muscle microenvironments. Direct comparisons of genomic and non-genomic effects of glucocorticoids and MRAs on skeletal muscles and heart will contribute to optimal temporal use of these drugs, since they compete for binding conserved receptors. Despite the advent of genetic medicines, therapies targeting inflammation and fibrosis will be necessary to achieve optimal patient outcomes.<\/jats:p>","DOI":"10.3389\/fphar.2022.942660","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:51:53Z","timestamp":1656377513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury"],"prefix":"10.3389","volume":"13","author":[{"given":"Zachary M.","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan K.","family":"Gomatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arden B.","family":"Piepho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Rafael-Fortney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ng0493-283","article-title":"The Structural and Functional Diversity of Dystrophin","volume":"3","author":"Ahn","year":"1993","journal-title":"Nat. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"112968","DOI":"10.1016\/j.yexcr.2021.112968","article-title":"Therapeutic Approaches to Preserve the Musculature in Duchenne Muscular Dystrophy: The Importance of the Secondary Therapies","volume":"410","author":"Angelini","year":"2022","journal-title":"Exp. Cell Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1084\/jem.20070075","article-title":"Inflammatory Monocytes Recruited after Skeletal Muscle Injury Switch into Antiinflammatory Macrophages to Support Myogenesis","volume":"204","author":"Arnold","year":"2007","journal-title":"J. Exp. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid Receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/PHM.0b013e3181e72207","article-title":"Duchenne Muscular Dystrophy: the Effect of Glucocorticoids on Ventilator Use and Ambulation","volume":"89","author":"Bach","year":"2010","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.kint.2017.12.016","article-title":"The Myeloid Mineralocorticoid Receptor Controls Inflammatory and Fibrotic Responses after Renal Injury via Macrophage Interleukin-4 Receptor Signaling","volume":"93","author":"Barrera-Chimal","year":"2018","journal-title":"Kidney Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","article-title":"The Role of the Glucocorticoid Receptor in Inflammation and Immunity","volume":"120","author":"Baschant","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archneur.62.1.128","article-title":"Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy: a Randomized Controlled Trial","volume":"62","author":"Beenakker","year":"2005","journal-title":"Arch. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000480652","article-title":"The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature","volume":"46","author":"Belden","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1152\/advan.00051.2001","article-title":"Aldosterone","volume":"26","author":"Booth","year":"2002","journal-title":"Adv. Physiol. Educ."},{"key":"B11","doi-asserted-by":"publisher","first-page":"C155","DOI":"10.1152\/ajpcell.00269.2016","article-title":"Renin-angiotensin-aldosterone System Inhibitors Improve Membrane Stability and Change Gene-Expression Profiles in Dystrophic Skeletal Muscles","volume":"312","author":"Chadwick","year":"","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physiolgenomics.00128.2016","article-title":"Gene Expression Effects of Glucocorticoid and Mineralocorticoid Receptor Agonists and Antagonists on Normal Human Skeletal Muscle","volume":"49","author":"Chadwick","year":"","journal-title":"Physiol. Genomics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1096\/fj.15-276782","article-title":"Mineralocorticoid Receptors Are Present in Skeletal Muscle and Represent a Potential Therapeutic Target","volume":"29","author":"Chadwick","year":"2015","journal-title":"FASEB J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5167","DOI":"10.1093\/hmg\/ddw331","article-title":"Myeloid Cells Are Capable of Synthesizing Aldosterone to Exacerbate Damage in Muscular Dystrophy","volume":"25","author":"Chadwick","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/s0960-8966(02)00180-3","article-title":"High Dose Weekly Oral Prednisone Improves Strength in Boys with Duchenne Muscular Dystrophy","volume":"12","author":"Connolly","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based Gene Therapies for the Muscular Dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1136\/heartjnl-2017-311269","article-title":"A Current Approach to Heart Failure in Duchenne Muscular Dystrophy","volume":"103","author":"D'amario","year":"2017","journal-title":"Heart"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne Muscular Dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/s0140-6736(88)90742-8","article-title":"Localisation of 11 Beta-Hydroxysteroid Dehydrogenase-Ttissue Specific Protector of the Mineralocorticoid Receptor","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, Blinded Trial of Weekend vs Daily Prednisone in Duchenne Muscular Dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jsbmb.2014.04.015","article-title":"Post-translational Modifications of the Mineralocorticoid Receptor: How to Dress the Receptor According to the Circumstances?","volume":"143","author":"Faresse","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCRESAHA.116.302706","article-title":"Role of Mineralocorticoid Receptor Antagonists in Cardiovascular Disease","volume":"116","author":"Ferrario","year":"2015","journal-title":"Circ. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","article-title":"The DMD Gene and Therapeutic Approaches to Restore Dystrophin","volume":"31","author":"Fortunato","year":"2021","journal-title":"Neuromuscul. Disord."},{"key":"B25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/HYPERTENSIONAHA.118.12162","article-title":"Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing","volume":"73","author":"Fraccarollo","year":"2019","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/STROKEAHA.110.598441","article-title":"Myeloid-specific Deletion of the Mineralocorticoid Receptor Reduces Infarct Volume and Alters Inflammation during Cerebral Ischemia","volume":"42","author":"Frieler","year":"2011","journal-title":"Stroke"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1530\/JOE-11-0372","article-title":"Mechanisms of Ligand Specificity of the Mineralocorticoid Receptor","volume":"213","author":"Fuller","year":"2012","journal-title":"J. Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/cphy.c130044","article-title":"The Multifaceted Mineralocorticoid Receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1210\/en.2004-0295","article-title":"Origin of Aldosterone in the Rat Heart","volume":"145","author":"Gomez-Sanchez","year":"2004","journal-title":"Endocrinology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/CIRCRESAHA.117.312380","article-title":"Pannexin 1 Channels as an Unexpected New Target of the Anti-hypertensive Drug Spironolactone","volume":"122","author":"Good","year":"2018","journal-title":"Circ. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/mt.2008.28","article-title":"Systemic Microdystrophin Gene Delivery Improves Skeletal Muscle Structure and Function in Old Dystrophic Mdx Mice","volume":"16","author":"Gregorevic","year":"2008","journal-title":"Mol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1085","article-title":"Systemic Delivery of Genes to Striated Muscles Using Adeno-Associated Viral Vectors","volume":"10","author":"Gregorevic","year":"2004","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1152\/japplphysiol.00313.2014","article-title":"Anti-inflammatory Macrophages Improve Skeletal Muscle Recovery from Ischemia-Reperfusion","volume":"118","author":"Hammers","year":"2015","journal-title":"J. Appl. Physiol. (1985)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1681\/ASN.2005111196","article-title":"Spironolactone Prevents Diabetic Nephropathy through an Anti-inflammatory Mechanism in Type 2 Diabetic Rats","volume":"17","author":"Han","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3389\/fphys.2019.01324","article-title":"Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair after Acute Injury","volume":"10","author":"Hauck","year":"","journal-title":"Front. Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/hmg\/ddz039","article-title":"Mineralocorticoid Receptor Antagonists Improve Membrane Integrity Independent of Muscle Force in Muscular Dystrophy","volume":"28","author":"Hauck","year":"","journal-title":"Hum. Mol. Genet."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic Aspects of Mineralocorticoid Receptor Activation","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146511","article-title":"Micro-dystrophin Gene Therapy Prevents Heart Failure in an Improved Duchenne Muscular Dystrophy Cardiomyopathy Mouse Model","volume":"6","author":"Howard","year":"","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.ajpath.2021.01.008","article-title":"Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity","volume":"191","author":"Howard","year":"","journal-title":"Am. J. Pathol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"C354","DOI":"10.1152\/ajpcell.00411.2021","article-title":"Myeloid Mineralocorticoid Receptors Contribute to Skeletal Muscle Repair in Muscular Dystrophy and Acute Muscle Injury","volume":"322","author":"Howard","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1210\/me.2005-0247","article-title":"The Evolution of Mineralocorticoid Receptors","volume":"20","author":"Hu","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The Ligand-dependent Interaction of Mineralocorticoid Receptor with Coactivator and Corepressor Peptides Suggests Multiple Activation Mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/jcp.2010.078204","article-title":"Steroid Therapy Is Associated with Decreased Numbers of Dendritic Cells and Fibroblasts, and Increased Numbers of Satellite Cells, in the Dystrophic Skeletal Muscle","volume":"63","author":"Hussein","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.nmd.2008.02.002","article-title":"Mdx Respiratory Impairment Following Fibrosis of the Diaphragm","volume":"18","author":"Ishizaki","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e88360","DOI":"10.1371\/journal.pone.0088360","article-title":"Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the Mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"9","author":"Janssen","year":"2014","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1210\/jcem.85.7.6663","article-title":"Steroidogenic Enzyme Gene Expression in the Human Heart","volume":"85","author":"Kayes-Wandover","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41434-021-00222-4","article-title":"Genome Editing for Duchenne Muscular Dystrophy: a Glimpse of the Future?","volume":"28","author":"Kupatt","year":"2021","journal-title":"Gene Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1161\/HYPERTENSIONAHA.117.09070","article-title":"Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction through Modulating T-Cell Activation","volume":"70","author":"Li","year":"2017","journal-title":"Hypertension"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e110950","DOI":"10.1371\/journal.pone.0110950","article-title":"Myeloid Mineralocorticoid Receptor Deficiency Inhibits Aortic Constriction-Induced Cardiac Hypertrophy in Mice","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JND-160173","article-title":"Similar Efficacy from Specific and Non-specific Mineralocorticoid Receptor Antagonist Treatment of Muscular Dystrophy Mice","volume":"3","author":"Lowe","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3233\/JND-180323","article-title":"Mineralocorticoid Receptor Antagonists in Muscular Dystrophy Mice during Aging and Exercise","volume":"5","author":"Lowe","year":"2018","journal-title":"J. Neuromuscul. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/JND-150099","article-title":"The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but Not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy","volume":"2","author":"Lowe","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1002\/ehf2.12996","article-title":"Mineralocorticoid Receptor Antagonism by Finerenone Is Sufficient to Improve Function in Preclinical Muscular Dystrophy","volume":"7","author":"Lowe","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1677\/jme.0.0240321","article-title":"Expression of 11beta-Hydroxylase and Aldosterone Synthase Genes in the Rat Brain","volume":"24","author":"Mackenzie","year":"2000","journal-title":"J. Mol. Endocrinol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"15457","DOI":"10.1074\/jbc.R200031200","article-title":"Dystrophin-glycoprotein Complex: Post-translational Processing and Dystroglycan Function","volume":"278","author":"Michele","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3389\/fimmu.2017.01319","article-title":"Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity","volume":"8","author":"Montes-Cobos","year":"2017","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00276340","article-title":"Regional Chromosomal Assignment of the Human Mineralocorticoid Receptor Gene to 4q31.1","volume":"85","author":"Morrison","year":"1990","journal-title":"Hum. Genet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1677\/JME-08-0093","article-title":"Structure-function Relationships in the Mineralocorticoid Receptor","volume":"41","author":"Pippal","year":"2008","journal-title":"J. Mol. Endocrinol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1172\/JCI91445","article-title":"Intermittent Glucocorticoid Steroid Dosing Enhances Muscle Repair without Eliciting Muscle Atrophy","volume":"127","author":"Quattrocelli","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/CIRCULATIONAHA.111.031716","article-title":"Early Treatment with Lisinopril and Spironolactone Preserves Cardiac and Skeletal Muscle in Duchenne Muscular Dystrophy Mice","volume":"124","author":"Rafael-Fortney","year":"2011","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e013501","DOI":"10.1161\/JAHA.119.013501","article-title":"Stabilization of Early Duchenne Cardiomyopathy with Aldosterone Inhibition: Results of the Multicenter AIDMD Trial","volume":"8","author":"Raman","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for Early Cardiomyopathy in Duchenne Muscular Dystrophy: a Randomised, Double-Blind, Placebo-Controlled Trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ymthe.2019.01.002","article-title":"Development of Novel Micro-dystrophins with Enhanced Functionality","volume":"27","author":"Ramos","year":"2019","journal-title":"Mol. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mce.2003.10.021","article-title":"Mineralocorticoid Receptor Binding, Structure and Function","volume":"217","author":"Rogerson","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","article-title":"Immune-mediated Pathology in Duchenne Muscular Dystrophy","volume":"7","author":"Rosenberg","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"T107","DOI":"10.1530\/JOE-16-0659","article-title":"30 YEARS of the MINERALOCORTICOID RECEPTOR: Nongenomic Effects via the Mineralocorticoid Receptor","volume":"234","author":"Ruhs","year":"2017","journal-title":"J. Endocrinol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced Skeletal Muscle Atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/en.2013-1772","article-title":"CCL2-dependent Macrophage Recruitment Is Critical for Mineralocorticoid Receptor-Mediated Cardiac Fibrosis, Inflammation, and Blood Pressure Responses in Male Mice","volume":"155","author":"Shen","year":"2014","journal-title":"Endocrinology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1074\/jbc.M116.739243","article-title":"Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis","volume":"292","author":"Shen","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B70","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/ATVBAHA.115.307031","article-title":"Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation through SGK1-Ap1\/nf-\u039ab Pathways","volume":"36","author":"Sun","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2003.10.012","article-title":"Vascular Synthesis of Aldosterone: Role in Hypertension","volume":"217","author":"Takeda","year":"2004","journal-title":"Mol. Cell Endocrinol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","article-title":"Immunobiology of Inherited Muscular Dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of Muscle Growth and Regeneration by the Immune System","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI41080","article-title":"Myeloid Mineralocorticoid Receptor Controls Macrophage Polarization and Cardiovascular Hypertrophy and Remodeling in Mice","volume":"120","author":"Usher","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B75","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00246-021-02807-7","article-title":"Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure through ACTION","volume":"43","author":"Villa","year":"2022","journal-title":"Pediatr. Cardiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/01.HYP.0000175814.18550.c0","article-title":"Local Renal Aldosterone System and its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor","volume":"46","author":"Xue","year":"2005","journal-title":"Hypertension"},{"key":"B77","doi-asserted-by":"publisher","first-page":"21016","DOI":"10.1074\/jbc.270.36.21016","article-title":"Human Mineralocorticoid Receptor Genomic Structure and Identification of Expressed Isoforms","volume":"270","author":"Zennaro","year":"1995","journal-title":"J. Biol. Chem."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/db16-1354","article-title":"Deletion of Macrophage Mineralocorticoid Receptor Protects Hepatic Steatosis and Insulin Resistance through ER\u03b1\/HGF\/Met Pathway","volume":"66","author":"Zhang","year":"2017","journal-title":"Diabetes"},{"key":"B79","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2007.08.029","article-title":"Haploinsufficiency of Utrophin Gene Worsens Skeletal Muscle Inflammation and Fibrosis in Mdx Mice","volume":"264","author":"Zhou","year":"2008","journal-title":"J. Neurol. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.942660\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:51:57Z","timestamp":1656377517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.942660\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":79,"alternative-id":["10.3389\/fphar.2022.942660"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.942660","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]},"article-number":"942660"}}